低级炎症评分:脑内动脉样硬化症患者中风复发的危险因素
Li Wu1, Guanfeng Zeng1, Kang Liu1
1Department of Neurology, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience, The Second Affiliated Hospital, Guangzhou Medical University, 250 Changgang East Road, Guangzhou, 510260, China.
Molecular neurobiology
|June 21, 2025
概括
慢性低度炎症 (LGI) 与动脉疾病有关. 较高的LGI得分可以独立预测内动脉缩狭窄症 (ICAS) 患者的复发性缺血性中风.
科学领域:
- 心血管研究研究心血管研究
- 神经学 神经学
- 炎症生物学 炎症生物学
背景情况:
- 动脉样硬化包括动脉中慢性低度炎症 (LGI).
- 较高的LGI得分与心脑血管疾病的发病和复发相关.
- 内动脉硬化狭窄症 (ICAS) 是缺血性中风的一个重要原因.
研究的目的:
- 研究ICAS患者的LGI得分和中风复发之间的关联.
- 确定LGI得分作为潜在的中风复发的独立风险因素.
主要方法:
- 未来的,多中心医院基的队列研究.
- 包括932名患有ICAS的急性缺血性中风患者,跟踪至少1年.
- 基于LGI四分位数的Cox回归和Kaplan-Meier生存曲线的分析.
主要成果:
- 80名患者在随访期间经历了复发性缺血性中风.
- 在LGI四分位数中,炎症标志物和中风复发的显著差异.
- 多变量分析显示,在LGI最高四分位数 (Q4) 与最低四分位数 (Q1) 相比,中风复发的危险比增加了2.748倍.
结论:
- 在ICAS患者中,LGI得分是缺血性中风复发的独立风险因素.
- 较高的LGI得分与复发性中风的风险增加有关.
- 对LGI的评估可能有助于对ICAS患者中风复发的风险分层.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
129
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
129
Inflammation
55.5K
Overview
55.5K
Atherosclerosis IV: Nursing Management
65
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
65
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
42
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
42
Atherosclerosis I: Introduction
93
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
93


